Proverum

6 results

ProVerum founders Ríona Ní Ghriallais and Conor Harkin
Irish prostate medtech ProVerum raises €30m in funding

Irish medtech company ProVerum has raised €30 million to support its clinical programme as it looks to go to market with its ground-breaking ProVee de(...)

Ireland ranked joint fourth in the first EIC accelerator call, with five Enterprise Ireland-backed companies recommended for more than €20.5 million in funding
Horizon Europe a key opportunity for Irish enterprise

More than 2,700 Irish companies and research institutions received more than €1.8 billion in funding from the European Union Horizon 2020 research and(...)

The Republic of Ireland ranks fourth in terms of the number of companies recommended for funding, alongside Denmark and behind France, Germany and the Netherlands
Five start-ups secure combined €20.5m in EU funding

Five Irish start-ups have received a combined €20.5 million in funding from the European Commission. AVeta Medical, Akara Robotics, CrannMED, Conteg(...)

Applications for the next round of funding for the European Innovation Council’s (EIC) € 164 million accelerator programme fund closes at 4pm Irish time on Wednesday
Start-ups urged to apply for EU funding to help combat coranavirus outbreak

The European Commission has issued an urgent call to start-ups and other small businesses with technologies that could help combat the coronavirus out(...)

Overall, €344 million is being provided in funding by the council to support SMEs, start-ups and researchers across Europe who are working on game-changing ideas
Irish companies and university researchers awarded €7m in EU funding

More than €7 million in research funding has been awarded to two Irish companies and three universities by the European Union. Dublin-based Proverum(...)

Dr Conor Harkin, founder of ProVerum: “Its unique design ensures normal urination and also preserves sexual function.”
ProVerum offers minimally invasive treatment for BPH

“More than a quarter of all men have symptomatic Benign prostatic hyperplasia (BPH) by the age of 50 and by age 80, approximately 80 per cent of men w(...)